The potential of the analgetic placebo effect s3guideline recommendation on the clinical use for acute and perioperative pain management;Das Potenzial des analgetischen Plazeboeffektes S3LeitlinienEmpfehlung zur Behandlung akuter und perioperativer Schmerzen

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 45, Issue 1, 2010, Pages 22-29

  Klinger, Regine ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PLACEBO;

ADD ON THERAPY; ANALGESIA; CLINICAL ASSESSMENT; DRUG EFFECT; DRUG EFFICACY; DRUG USE; HUMAN; PAIN; PAIN ASSESSMENT; PERIOPERATIVE PERIOD; PLACEBO EFFECT; PRACTICE GUIDELINE; REVIEW;

ACUTE DISEASE; ANALGESICS; ENDORPHINS; GUIDELINES AS TOPIC; HUMANS; PAIN, POSTOPERATIVE; PERIOPERATIVE CARE; PLACEBO EFFECT; PLACEBOS;

EID: 76249124081     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0029-1243374     Document Type: Review

References (36)

1. Deutsche Interdisziplinäre Vereinigung für Schmerztherapie (DIVS). S3Leitlinie "Behandlung akuter perioperativer und posttraumatischer Schmerzen". Köln: Deutscher ÄrzteVerlag 2008
2. Brody H, Brody D. The Placebo Response. New York: Cliff Street Books 2000
3. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008 136 211-218
4. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008 59 195-206
5. Moerman DE. Meaningful dimensions of medical care. In: Guess HA, Kleinman A, Kusek JW, Engel LW, Hrsg. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London: BMJ Books 2002
6. Gauler TC, Weihrauch TR. Placebo ein wirksames und ungefährliches Medikament? München: Urban und Schwarzenberg 1997
7. Thomas R. Side effects and placebo amplification. British Journal of Psychiatry 1982 140 64-68
8. Leslie A. Ethics and practice of placeo therapy. Amer J Med 1954 16 854-862
9. De Craen AJ M, Tijssen JG, De Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000 247 183-188
10. Laska E, Sunshine A. Anticipation of analgesia: a placebo effect. Headache 1973 13 1-11
11. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet 2001 357 757-762
12. Price DD, Finniss DG, Benedetti F. A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought. Annual Review of Psychology 2008 59 565-590
13. Benedetti F, et al. A Open versus hidden medical treatments: The patient?s knowledge about a therapy effects the therapy outcome. Prevention and treatment. Prevention & Treatment 2003; 6. www.journals.apa.org/prevention/ volume6/pre0060001a.html
14. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: A role for nonspecific activation of endogenous opioids. Pain 2001 90 205-215 (Pubitemid 32162942)
15. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978 2 654-657
16. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 1996 64 535-543
17. Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by targetexpectations of analgesia. J Neurosci 1999 9 3639-3648
18. Lipman JJ, et al. Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response. Psychopharmacology 1990 102 112-116
19. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science 2002 295 1737-1740
20. Wager T, et al. Placeboinduced changes in fMRI in the anticipation and experience of pain. Science 2004 303 1162-1167
21. Zubieta JK, et al. Placebo effects mediated by endogenous opioid activity on opioid receptors. J Neurosci 2005 25 7754-7762
22. Eippert F, et al. Activation of the Opioidergic Descending Pain Control System Underlies Placebo Analgesia. Neuron 2009 63 533-543
23. Vase L, Riley III JL, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002 99 443-452
24. Klinger R, Soost S, Flor H, Worm M. Classical conditioning and expectancy in placebo hypoalgesia: A randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain 2007 128 31-39
25. WilliamsStewart S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 2004 130 324-340
26. Kirsch I, Lynn SJ, Vigorito M, Miller RR. The role of Cognition in Classical an Operant Conditioning. Journal of Clinical Psychology 2004 60 369-392
27. Ader R. The role of conditioning in pharmacotherapy. In: Harrington A, Hrsg. The placebo effect: An interdisciplinary exploration. Cambridge: Cambridge UP 1997
28. Wickramasekera I. A conditioned response model of the placebo effect: Predictions from the model. Biofeedback SelfRegulation 1980 5 5-18
29. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol 1985 40 1189-1202
30. Kirsch I. Specifying nonspecifics: Psychological mechanisms of placebo effects. In: Harrington A, Hrsg. The placebo effect: An interdisciplinary exploration, Cambridge: Cambridge UP 1997
31. Turner JA, Deyo RA, Loeser JD, von Korff M, Fordyce WE. The Importance of Placebo Effects in Pain Treatment and Research. JAMA 1994 271 1609-1614
32. Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 2005 114 3-6
33. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific Medication Side Effects and the Nocebo Phenomenon. JAMA 2002 5 622-627
34. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. J Neuroscience 2003 23 4315-4323
35. Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 1995 346 1231-1231
36. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety and Parkinson's disease. Lancet Neurol 2004 3 679-684